176 related articles for article (PubMed ID: 21873884)
1. Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration.
Zhu XY; Urbieta Caceres VH; Favreau FD; Krier JD; Lerman A; Lerman LO
J Hypertens; 2011 Oct; 29(10):1972-9. PubMed ID: 21873884
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.
Eirin A; Zhu XY; Ebrahimi B; Krier JD; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
Cell Transplant; 2015; 24(10):2041-53. PubMed ID: 25420012
[TBL] [Abstract][Full Text] [Related]
3. Preserved function of late-outgrowth endothelial cells in medically treated hypertensive patients under well-controlled conditions.
Chen Z; Herrmann SM; Zhu X; Jordan KL; Gloviczki ML; Lerman A; Textor SC; Lerman LO
Hypertension; 2014 Oct; 64(4):808-14. PubMed ID: 25047576
[TBL] [Abstract][Full Text] [Related]
4. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.
Urbieta-Caceres VH; Zhu XY; Jordan KL; Tang H; Textor K; Lerman A; Lerman LO
Atherosclerosis; 2012 Apr; 221(2):350-8. PubMed ID: 22341593
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs.
Lavi R; Zhu XY; Chade AR; Lin J; Lerman A; Lerman LO
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):976-83. PubMed ID: 20203299
[TBL] [Abstract][Full Text] [Related]
6. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.
Chade AR; Williams ML; Guise E; Vincent LJ; Harvey TW; Kuna M; Mahdi F; Bidwell GL
Kidney Int; 2018 Apr; 93(4):842-854. PubMed ID: 29273331
[TBL] [Abstract][Full Text] [Related]
7. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure.
Favreau F; Zhu XY; Krier JD; Lin J; Warner L; Textor SC; Lerman LO
Kidney Int; 2010 Dec; 78(11):1110-8. PubMed ID: 20463652
[TBL] [Abstract][Full Text] [Related]
8. Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.
Guise E; Engel JE; Williams ML; Mahdi F; Bidwell GL; Chade AR
Am J Physiol Renal Physiol; 2019 May; 316(5):F1016-F1025. PubMed ID: 30892933
[TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.
Chade AR; Zhu X; Lavi R; Krier JD; Pislaru S; Simari RD; Napoli C; Lerman A; Lerman LO
Circulation; 2009 Feb; 119(4):547-57. PubMed ID: 19153272
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs.
Zhu XY; Daghini E; Chade AR; Napoli C; Ritman EL; Lerman A; Lerman LO
J Am Soc Nephrol; 2007 Apr; 18(4):1209-17. PubMed ID: 17344424
[TBL] [Abstract][Full Text] [Related]
11. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner.
Salguero G; Akin E; Templin C; Kotlarz D; Doerries C; Landmesser U; Grote K; Schieffer B
J Hypertens; 2008 Feb; 26(2):257-68. PubMed ID: 18192840
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension.
Sadjadi J; Puttaparthi K; Welborn MB; Rogers TE; Moe O; Clagett GP; Turnage RH; Levi M; Modrall JG
J Vasc Surg; 2002 Aug; 36(2):386-92. PubMed ID: 12170196
[TBL] [Abstract][Full Text] [Related]
13. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.
Chade AR; Kelsen S
Am J Physiol Renal Physiol; 2012 May; 302(10):F1342-50. PubMed ID: 22357917
[TBL] [Abstract][Full Text] [Related]
14. Split intrarenal hemodynamics in renovascular hypertension.
Kimura G; London GM; Safar ME; Kuramochi M; Omae T
Clin Invest Med; 1991 Dec; 14(6):559-65. PubMed ID: 1794208
[TBL] [Abstract][Full Text] [Related]
15. Role of renal microcirculation in experimental renovascular disease.
Iliescu R; Fernandez SR; Kelsen S; Maric C; Chade AR
Nephrol Dial Transplant; 2010 Apr; 25(4):1079-87. PubMed ID: 19934087
[TBL] [Abstract][Full Text] [Related]
16. Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.
Sun D; Eirin A; Ebrahimi B; Textor SC; Lerman A; Lerman LO
J Am Soc Hypertens; 2016 Apr; 10(4):325-35. PubMed ID: 26879682
[TBL] [Abstract][Full Text] [Related]
17. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
18. Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.
Eirin A; Zhu XY; Ferguson CM; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
Stem Cell Res Ther; 2015 Jan; 6(1):7. PubMed ID: 25599803
[TBL] [Abstract][Full Text] [Related]
19. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease.
Engel JE; Williams ML; Williams E; Azar C; Taylor EB; Bidwell GL; Chade AR
Am J Nephrol; 2020; 51(11):891-902. PubMed ID: 33130676
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.
Park MY; Herrmann SM; Saad A; Eirin A; Tang H; Lerman A; Textor SC; Lerman LO
Clin J Am Soc Nephrol; 2015 Mar; 10(3):443-51. PubMed ID: 25542906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
